Hypertension in the Hispanic-American population

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

According to the 1988 census, there are 19.4 million Hispanics living in the United States. They represent 8.1 percent of the nation's population, and that percentage is expected to rise significantly in the next 25 years. Demographic projections indicate that Hispanics will become the largest minority group in the United States by the year 2000, yet they remain a seriously understudied population. This article examines available clinical data, epidemiologic findings, and sociologic observations regarding the incidence of hypertension in this minority group and summarizes what is known about the detection, evaluation, treatment, and control of high blood pressure in Hispanics. In addition, the preliminary results of a multi-center, placebo-controlled trial comparing the efficacy and safety of a potassium-sparing diuretic (Dyazide®; Smith Kline & French Laboratories) in Hispanic-American patients with mild-to-moderate hypertension are presented.

Original languageEnglish
JournalThe American Journal of Medicine
Volume88
Issue number3 SUPPL. 2
DOIs
StatePublished - Mar 12 1990

Fingerprint

Hispanic Americans
Hypertension
Minority Groups
Population
Potassium Sparing Diuretics
Censuses
Placebos
Demography
Safety
Incidence
Therapeutics

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Hypertension in the Hispanic-American population. / Caralis, Panagiota V.

In: The American Journal of Medicine, Vol. 88, No. 3 SUPPL. 2, 12.03.1990.

Research output: Contribution to journalArticle

@article{eb8c23046f834ef0b37819f478b9ddf2,
title = "Hypertension in the Hispanic-American population",
abstract = "According to the 1988 census, there are 19.4 million Hispanics living in the United States. They represent 8.1 percent of the nation's population, and that percentage is expected to rise significantly in the next 25 years. Demographic projections indicate that Hispanics will become the largest minority group in the United States by the year 2000, yet they remain a seriously understudied population. This article examines available clinical data, epidemiologic findings, and sociologic observations regarding the incidence of hypertension in this minority group and summarizes what is known about the detection, evaluation, treatment, and control of high blood pressure in Hispanics. In addition, the preliminary results of a multi-center, placebo-controlled trial comparing the efficacy and safety of a potassium-sparing diuretic (Dyazide{\circledR}; Smith Kline & French Laboratories) in Hispanic-American patients with mild-to-moderate hypertension are presented.",
author = "Caralis, {Panagiota V.}",
year = "1990",
month = "3",
day = "12",
doi = "10.1016/0002-9343(90)90004-W",
language = "English",
volume = "88",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "3 SUPPL. 2",

}

TY - JOUR

T1 - Hypertension in the Hispanic-American population

AU - Caralis, Panagiota V.

PY - 1990/3/12

Y1 - 1990/3/12

N2 - According to the 1988 census, there are 19.4 million Hispanics living in the United States. They represent 8.1 percent of the nation's population, and that percentage is expected to rise significantly in the next 25 years. Demographic projections indicate that Hispanics will become the largest minority group in the United States by the year 2000, yet they remain a seriously understudied population. This article examines available clinical data, epidemiologic findings, and sociologic observations regarding the incidence of hypertension in this minority group and summarizes what is known about the detection, evaluation, treatment, and control of high blood pressure in Hispanics. In addition, the preliminary results of a multi-center, placebo-controlled trial comparing the efficacy and safety of a potassium-sparing diuretic (Dyazide®; Smith Kline & French Laboratories) in Hispanic-American patients with mild-to-moderate hypertension are presented.

AB - According to the 1988 census, there are 19.4 million Hispanics living in the United States. They represent 8.1 percent of the nation's population, and that percentage is expected to rise significantly in the next 25 years. Demographic projections indicate that Hispanics will become the largest minority group in the United States by the year 2000, yet they remain a seriously understudied population. This article examines available clinical data, epidemiologic findings, and sociologic observations regarding the incidence of hypertension in this minority group and summarizes what is known about the detection, evaluation, treatment, and control of high blood pressure in Hispanics. In addition, the preliminary results of a multi-center, placebo-controlled trial comparing the efficacy and safety of a potassium-sparing diuretic (Dyazide®; Smith Kline & French Laboratories) in Hispanic-American patients with mild-to-moderate hypertension are presented.

UR - http://www.scopus.com/inward/record.url?scp=0025270299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025270299&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(90)90004-W

DO - 10.1016/0002-9343(90)90004-W

M3 - Article

VL - 88

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 3 SUPPL. 2

ER -